Lidia Fonseca - 25 Feb 2026 Form 4 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
/s/ Shanice A. Reid, by power of atty, for Lidia Fonseca
Issuer symbol
PFE
Transactions as of
25 Feb 2026
Net transactions value
+$439,834
Form type
4
Filing time
27 Feb 2026, 18:34:06 UTC
Previous filing
30 Apr 2025
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fonseca Lidia Executive Vice President 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK /s/ Shanice A. Reid, by power of atty, for Lidia Fonseca 27 Feb 2026 0001454944

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $1,923,952 +56,888 +127% $33.82 101,579 25 Feb 2026 Direct F1
transaction PFE Common Stock Tax liability $28,661 -1,058 -1% $27.09 100,521 25 Feb 2026 Direct F2
transaction PFE Common Stock Tax liability $1,455,457 -54,066 -54% $26.92 46,455 25 Feb 2026 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -56,888 -100% $0.000000 0 25 Feb 2026 Common Stock 56,888 $33.82 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.